An Uncommon Case of Cerebellar Leukoencephalopathy Secondary to Low-Dose Methotrexate
Methotrexate (MTX) is a commonly used disease-modifying antirheumatic drug in the treatment of rheumatoid arthritis (RA). MTX neurotoxicity in an RA population is uncommon, with few case reports describing this phenomenon.<sup>1-3</sup>
Authors
- Tai‐Juan Aw (ORCID: https://orcid.org/0000-0001-8363-9499)
- Sharmayne R.E. Brady (ORCID: https://orcid.org/0000-0002-8358-3015)
- Dana Yen Lin Lee (ORCID: https://orcid.org/0000-0002-2136-7632)
Institutions
- Arthritis Australia (AU)
- Peninsula Health (AU)
- Alfred Health (AU)
- Monash University (AU)
Publication Details
- Journal
- The Journal of Rheumatology
- Published
- 2025-11-15
- DOI
- https://doi.org/10.3899/jrheum.2025-0776
- Primary Topic
- Neurological Complications and Syndromes
- Type
- article
- Field-Weighted Citation Impact
- 0.00